Obstetric emergencies
Verified clinical guidelines and emergency management protocols.
Protocol Content
Navigation
🔴 POSTPARTUM HAEMORRHAGE (PPH)
COMPREHENSIVE CLINICAL PROTOCOL FOR INDIAN HEALTHCARE SETTINGS
For Healthcare Professionals Only | Aligned with WHO 2023, FIGO 2022, FOGSI, LaQshya Guidelines
SECTION 1: FUNDAMENTALS
1.1 DEFINITIONS
| Term | Definition | Clinical Significance |
|
PPH (Traditional - Vaginal)
|
Blood loss ≥500 mL after vaginal delivery | Threshold for documentation; often underestimates true loss |
|
PPH (Traditional - CS)
|
Blood loss ≥1000 mL after caesarean section | Higher baseline expected loss in CS |
|
Severe PPH
|
Blood loss ≥1000 mL regardless of mode | Requires aggressive intervention |
|
Clinical PPH (Preferred)
|
Blood loss causing haemodynamic instability OR requiring intervention | Most practical definition; treat the patient, not the number |
|
Primary PPH
|
Within 24 hours of delivery | Most common, most dangerous |
|
Secondary PPH
|
24 hours to 12 weeks postpartum | Usually infection or retained products |
🚨 Clinical Pearl: Visual estimation underestimates blood loss by 30-50%. A soaked maternity pad holds ~100 mL; a soaked under-buttock drape holds ~500-1000 mL. When in doubt, treat as PPH.
1.2 EPIDEMIOLOGY (INDIA-SPECIFIC)
| Parameter | Data |
| Incidence | 2-4% of all deliveries; up to 6% in some settings |
| Maternal mortality contribution | 38% of direct maternal deaths (leading cause) |
| Case fatality rate | 1% (higher in rural/resource-limited settings) |
| Time to death | Can occur within 2 hours if untreated |
Why Indian Women Are More Vulnerable:
- High prevalence of anaemia (Hb <11 g/dL in >50% of pregnant women)
- Malnutrition
- High fertility rates
- Home deliveries without skilled attendants
- Delayed recognition and referral
- Limited blood bank access
1.3 AETIOLOGY: THE 4 Ts (In Order of Frequency)
TONE (70-80%) – Uterine Atony
| Risk Factors | Mechanism |
|
Overdistended uterus
|
Multiple pregnancy, polyhydramnios, macrosomia (>4 kg) |
|
Uterine muscle fatigue
|
Prolonged labour, rapid labour (precipitate), prolonged oxytocin use |
|
Uterine muscle impairment
|
Grand multiparity (≥5), previous PPH, fibroids, chorioamnionitis |
|
Drug-induced relaxation
|
MgSO₄, tocolytics (terbutaline, nifedipine), halogenated anaesthetics |
|
Other
|
Full bladder (prevents contraction), uterine inversion |
TRAUMA (10-20%) – Genital Tract Injury
| Type | Causes | Clinical Features |
|
Perineal tears
|
Precipitate delivery, large baby, instrumental delivery | Visible bleeding from perineum |
|
Vaginal tears
|
Instrumental delivery, malpresentation | Bleeding with contracted uterus |
|
Cervical tears
|
Rapid dilatation, pushing before full dilatation | Bleeding despite contracted uterus; need speculum exam |
|
Uterine rupture
|
Previous CS, obstructed labour, oxytocin excess | Sudden pain, shock, loss of contractions |
|
Uterine inversion
|
Cord traction before separation, fundal pressure | Mass at/outside introitus, shock out of proportion |
|
Broad ligament haematoma
|
Extension of uterine incision (CS), instrumental | Expanding pelvic mass, shock |
TISSUE (5-10%) – Retained Products
| Type | Causes | Clinical Features |
|
Retained placenta
|
Placenta accreta spectrum, manual removal failure | Placenta not delivered within 30 min |
|
Retained cotyledon/membrane
|
Incomplete placental examination | Uterus doesn’t contract fully; check placenta |
|
Retained blood clots
|
Atony, coagulopathy | Soft uterus despite uterotonics; clots on massage |
|
Succenturiate lobe
|
Abnormal placentation | Vessels running to edge of membranes |
THROMBIN (1-2%) – Coagulopathy
| Type | Causes | Clinical Features |
|
Pre-existing
|
Von Willebrand disease, haemophilia carriers, ITP, anticoagulant use | Known history; bleeding from multiple sites |
|
Acquired - Pregnancy
|
Severe preeclampsia/HELLP, placental abruption, amniotic fluid embolism, IUFD (especially >4 weeks) | Oozing from IV sites, wound, no clot formation |
|
Acquired - Dilutional
|
Massive crystalloid resuscitation, massive transfusion without FFP | After large volume replacement |
|
DIC
|
Abruption, sepsis, AFE, IUFD | Consumptive; low fibrinogen, prolonged PT/aPTT |
1.4 RISK STRATIFICATION
Antenatal Risk Assessment
| Risk Level | Factors | Action |
|
HIGH RISK
|
Previous PPH, placenta praevia, suspected accreta, multiple pregnancy, polyhydramnios, large fibroids, bleeding disorder, severe anaemia (Hb <7), anticoagulant use | Deliver at CEmONC facility with blood bank; Group & Save/Crossmatch; senior obstetrician; anaesthesia standby |
|
MODERATE RISK
|
Grand multiparity (≥5), previous CS, overdistended uterus, Hb 7-9, obesity | Deliver at facility with blood transfusion capability; Group & Save; IV access before delivery |
|
LOW RISK
|
No risk factors identified | Routine AMTSL; be prepared (PPH can occur without risk factors) |
⚠️ 40% of PPH occurs in women with NO identifiable risk factors. Always be prepared.
Intrapartum Risk Assessment (Reassess Continuously)
| New Risk Factor | Action |
| Prolonged first stage (>12h nullipara, >10h multipara) | Prepare blood, senior involvement |
| Prolonged second stage | Consider instrumental vs CS; have uterotonics ready |
| Chorioamnionitis | IV antibiotics; anticipate atony |
| Instrumental delivery | Check for trauma; have sutures ready |
| Emergency CS | Anticipate higher blood loss |
| MgSO₄ use | Atony risk increased |
SECTION 2: PREVENTION
2.1 ACTIVE MANAGEMENT OF THIRD STAGE OF LABOUR (AMTSL)
Reduces PPH by 60-70% – Should be offered to ALL women
Components
| Component | Technique | Timing |
|
1. Prophylactic Uterotonic
|
Oxytocin 10 IU IM (preferred) OR IV over 1-2 min | Within 1 minute of delivery of baby |
|
2. Controlled Cord Traction (CCT)
|
Apply steady traction on cord while providing counter-traction above pubic symphysis | Only when uterus contracted and cord lengthening |
|
3. Uterine Massage
|
Gentle fundal massage after placental delivery | Until uterus well-contracted |
Preferred Uterotonic for Prophylaxis
| Drug | Dose | Route | Notes |
|
Oxytocin
|
10 IU | IM (preferred) or slow IV | First choice; safest profile |
|
Carbetocin
|
100 mcg | Single IM/IV dose | Longer acting; useful where cold chain limited |
|
Oxytocin + Ergometrine (Syntometrine)
|
5 IU + 0.5 mg | IM | More effective but more side effects; avoid in HTN |
|
Misoprostol
|
600 mcg | Oral | Where oxytocin unavailable; more side effects |
Controlled Cord Traction Technique
TECHNIQUE:
1. Wait for signs of placental separation:
- Uterus becomes globular and firm
- Gush of blood
- Cord lengthens
- Uterus rises in abdomen
2. Clamp cord close to perineum; hold with one hand
3. Place other hand suprapubically, palm facing toward
umbilicus (counter-traction hand)
4. Apply steady, gentle downward traction on cord while
pushing uterus upward/backward with counter-traction hand
5. If placenta doesn't descend with 30-40 sec of traction:
- Stop pulling
- Wait for next contraction
- Try again
6. Once placenta visible at introitus, use both hands to
gently rotate and ease out membranes
7. NEVER use excessive force – risk of uterine inversion
Examination of Placenta
CHECKLIST:
□ Maternal surface: All cotyledons present? Missing piece?
□ Fetal surface: Vessels run to edge? (succenturiate lobe if yes)
□ Membranes: Complete? Hole suggesting missing lobe?
□ Cord: Length, insertion, number of vessels (2 arteries, 1 vein)
□ Abnormalities: Infarcts, calcifications, tumours
DOCUMENT: Placenta complete/incomplete, weight if abnormal,
sent for histopathology if indicated
2.2 DELAYED CORD CLAMPING
| Recommendation | Details |
| Timing | Clamp cord 1-3 minutes after delivery (if baby vigorous) |
| Benefit | Increased neonatal haemoglobin, iron stores |
| Exception | If mother bleeding heavily OR baby needs resuscitation → clamp immediately |
2.3 PREPARING FOR PPH (HIGH-RISK CASES)
Pre-Delivery Checklist (High-Risk Woman)
□ IV access established (16-18G, preferably 2 lines)
□ Blood group and crossmatch sent (2-4 units PRBC)
□ Hb, platelets, coagulation if indicated
□ Uterotonics at bedside:
- Oxytocin 10 IU ampules × 5
- Misoprostol 200 mcg tablets × 5
- Methylergometrine 0.2 mg × 2 (if no contraindication)
- Carboprost 250 mcg × 2 (if available, no contraindication)
□ Tranexamic acid 1 g × 2 at bedside
□ IV fluid (NS/RL) running or ready
□ Blood warmer and pressure bag available
□ UBT (Uterine Balloon Tamponade) kit available
□ Senior obstetrician informed
□ Anaesthesia informed
□ Blood bank informed of high-risk case
□ Neonatal team standby
□ Emergency OT on standby (for highest risk: accreta)
SECTION 3: RECOGNITION AND INITIAL RESPONSE
3.1 RECOGNITION
Clinical Signs of PPH
| Sign | What to Look For |
|
Visible bleeding
|
Continuous trickle, gush, soaking drapes, pooling |
|
Uterine fundus
|
Soft, boggy, above umbilicus (atony) vs firm (trauma/tissue) |
|
Vital signs
|
Tachycardia, hypotension, tachypnoea |
|
Patient symptoms
|
Weakness, dizziness, thirst, confusion, restlessness |
|
Appearance
|
Pallor, cold/clammy, air hunger |
Obstetric Shock Index (OSI)
Shock Index = Heart Rate ÷ Systolic Blood Pressure
| SI Value | Interpretation | Estimated Blood Loss | Required Action |
| 0.7-0.9 | Normal | <500 mL | Monitor, continue routine care |
| 0.9-1.1 | Mild shock | 500-1000 mL | Alert team, prepare interventions |
| 1.1-1.5 | Moderate shock | 1000-1500 mL |
Aggressive intervention
|
| >1.5 | Severe shock | >1500 mL |
Massive transfusion protocol
|
🚨 Why Shock Index Matters: Pregnant women maintain BP until 30-40% blood volume lost due to physiological hypervolaemia. By the time BP drops, patient is in severe shock. Tachycardia and rising SI are earlier warning signs.
Quantitative Blood Loss Measurement
| Method | Technique |
|
Weighing
|
Weigh blood-soaked items; 1 g = 1 mL blood (subtract dry weight) |
|
Graduated drapes
|
Calibrated under-buttock drapes |
|
Estimation aids
|
Visual guides showing soaked swabs, drapes, etc. |
Visual Estimation Guide:
| Item | Approximate Blood Volume |
| Fully soaked maternity pad | 100 mL |
| Fully soaked incontinence pad (large) | 250 mL |
| Blood clot (fist-sized) | 500 mL |
| Fully soaked under-buttock drape | 500-1000 mL |
| Kidney dish (full) | 500 mL |
3.2 CALL FOR HELP – FIRST ACTION
🚨 PPH DECLARED – IMMEDIATELY:
□ Call: "I need help – PPH in [location]"
□ Designate:
- Team leader (usually senior obstetrician)
- Person for drugs/fluids
- Person for documentation/time-keeping
- Person for communication (blood bank, OT, ICU)
□ Start timer (or note time)
□ Inform:
- Senior obstetrician (if not present)
- Anaesthetist
- Blood bank
- Nursing supervisor (for additional staff)
□ Move PPH trolley/kit to bedside
PPH Trolley Contents:
| Category | Items |
|
Uterotonics
|
Oxytocin 10 IU × 10, Misoprostol 200 mcg × 10, Methylergometrine 0.2 mg × 5, Carboprost 250 mcg × 4 (refrigerated) |
|
Tranexamic acid
|
1 g ampules × 4 |
|
IV supplies
|
16G & 18G cannulas × 4 each, IV sets × 4, 3-way stopcock × 2 |
|
Fluids
|
NS 1L × 4, RL 1L × 4 |
|
Blood administration
|
Blood giving sets × 4, blood warmer if available |
|
UBT
|
Bakri balloon OR Condom catheter kit (Foley 22-24F, condom, silk tie) |
|
Instruments
|
Sponge holding forceps × 2, ovum forceps, Sims speculum, suture material |
|
Drugs
|
Calcium gluconate 10% × 2, Adrenaline 1:1000 × 2, Atropine × 2 |
|
Monitoring
|
BP cuff, pulse oximeter, thermometer |
|
Documentation
|
PPH checklist, observation chart, timer |
3.3 INITIAL RESUSCITATION (FIRST 5 MINUTES)
A – Airway and Breathing
| Action | Details |
| Position | Flat with legs elevated OR left lateral if still in labour |
| Airway | Ensure patent; suction if vomiting |
| Oxygen | 8-10 L/min via face mask with reservoir (target SpO₂ ≥95%) |
C – Circulation
| Action | Details |
|
IV Access
|
2 large-bore cannulas (16G or 18G) – antecubital fossa preferred |
| If difficult: external jugular, femoral, or intraosseous (EZ-IO) | |
|
Bloods
|
CBC, Group & crossmatch, PT/aPTT/fibrinogen, RFT, LFT |
| ABG with lactate if available | |
|
Crystalloid
|
1-2 L NS or RL rapid bolus (use pressure bag/hand squeeze) |
|
Warming
|
Warm fluids if possible; warm blankets |
|
Catheterize
|
Insert Foley; empty bladder (helps uterine contraction); monitor output |
Fluid Resuscitation Strategy
| Phase | Volume | Endpoint |
|
Initial bolus
|
1-2 L crystalloid over 10-15 min | Assess response |
|
Ongoing
|
Titrate to response | SBP >90, MAP ≥65, UO ≥0.5 mL/kg/hr |
|
Caution
|
Avoid >2L crystalloid without blood | Dilutional coagulopathy, pulmonary oedema |
⚠️ Crystalloid replaces volume, not oxygen-carrying capacity. In ongoing haemorrhage, early blood is critical.
SECTION 4: CAUSE IDENTIFICATION AND TARGETED TREATMENT
4.1 SIMULTANEOUS ASSESSMENT (While Resuscitating)
RAPID ASSESSMENT CHECKLIST:
□ UTERUS: Palpate fundus
- Soft/boggy → ATONY (most likely)
- Firm/contracted → Look for TRAUMA or TISSUE
□ VAGINA/PERINEUM: Inspect
- Active bleeding from tear → TRAUMA
- Clots in vagina → Empty and reassess
□ PLACENTA: Check
- Not delivered → Retained placenta
- Incomplete → Retained tissue
- Complete → Reassess cause
□ CERVIX: Speculum exam (if uterus contracted)
- Cervical tear → TRAUMA
□ BLEEDING CHARACTER:
- Clotting normally → Unlikely THROMBIN defect
- Not clotting, oozing from IV sites → THROMBIN issue
4.2 TREATMENT BY CAUSE
TONE – Uterine Atony Management
Step 1: Uterine Massage (Immediate)
TECHNIQUE – BIMANUAL UTERINE MASSAGE:
External only (initial):
- Cup hand over fundus through abdomen
- Firm, circular, rubbing motion
- "Rub up a contraction"
Bimanual (if no response):
- One hand: Fist in anterior vaginal fornix,
pushing up against lower segment
- Other hand: On abdomen, pressing down on fundus
- Compress uterus between both hands
- Maintain for several minutes until firm
- Can be tiring – may need to rotate personnel
Step 2: Empty Bladder
- Insert Foley catheter if not already done
- Full bladder prevents uterine contraction
- Also allows urine output monitoring
Step 3: Uterotonics (Start All Indicated Simultaneously)
| Drug | Dose & Route | Onset | Notes |
|
Oxytocin (First line)
|
10 IU IM OR slow IV (over 1-2 min) | 2-3 min (IM), immediate (IV) | Maximum bolus 10 IU |
|
Oxytocin infusion
|
20-40 IU in 500 mL NS at 125-250 mL/hr | Continuous | Titrate to uterine tone; max ~60 IU total |
|
Misoprostol
|
800 mcg sublingual (fastest) OR 1000 mcg rectal | 10-15 min | Use if oxytocin unavailable or as add-on; SE: fever, shivering |
|
Methylergometrine
|
0.2 mg IM (preferred) or slow IV | 2-5 min | ❌ Contraindicated: HTN, preeclampsia, cardiac disease |
|
Carboprost (PGF2α)
|
250 mcg deep IM q15-20 min (max 8 doses = 2 mg) | 5-15 min | ❌ Contraindicated: asthma, pulmonary/cardiac/renal disease; store refrigerated |
|
Carbetocin
|
100 mcg single IV/IM dose | Similar to oxytocin | Longer acting; may use instead of oxytocin infusion |
Uterotonic Escalation Protocol:
TIME 0: PPH recognized
├── Oxytocin 10 IU IM/IV + Start oxytocin infusion
├── Continue uterine massage
│
+5 min: Assess – if still bleeding/atonic
├── Add Misoprostol 800 mcg SL
├── Consider Methylergometrine 0.2 mg IM (if no contraindication)
│
+10-15 min: Assess – if still bleeding/atonic
├── Add Carboprost 250 mcg IM (if no contraindication)
├── Prepare for mechanical/surgical interventions
│
+15-20 min: Assess – if still bleeding
├── Proceed to UBT or surgical options
🚨 Do NOT delay escalation. Time is critical. All uterotonics can be given together if needed.
Step 4: Tranexamic Acid (Give Early)
| Parameter | Details |
|
Dose
|
1 g (10 mL of 100 mg/mL solution) IV over 10 minutes |
|
Timing
|
As soon as PPH diagnosed – within 3 hours of birth
|
|
Repeat
|
Second 1 g IV if bleeding continues after 30 minutes OR if bleeding restarts within 24 hours |
|
Evidence
|
WOMAN Trial: 20-30% reduction in death from bleeding if given within 3 hours |
|
Mechanism
|
Inhibits plasmin → reduces fibrin breakdown → stabilizes clot |
🚨 TXA efficacy decreases 10% for every 15 minutes of delay. NO BENEFIT after 3 hours. Give EARLY.
Contraindications to TXA (rare in acute PPH):
- Active thromboembolic disease
- Clear contraindication to antifibrinolytics
- In practice, these rarely apply in acute PPH – save life first
TRAUMA – Genital Tract Injury Management
Systematic Examination
EXAMINATION SEQUENCE:
1. GOOD LIGHTING – essential
2. ADEQUATE EXPOSURE – legs in lithotomy
3. ADEQUATE ANALGESIA – local, regional, or GA as needed
4. ASSISTANT – to hold retractors
Start from outside, work in:
□ PERINEUM:
- First/second degree tears → Repair
- Third/fourth degree → Senior surgeon, OT, proper repair
□ VAGINA:
- Use Sims speculum or retractors
- Inspect all walls systematically
- Pack and clamp bleeding areas
□ CERVIX:
- Use sponge-holding forceps to grasp lips
- Inspect entire circumference
- Common at 3 o'clock and 9 o'clock positions
□ UTERUS:
- If rupture suspected → laparotomy
- If inversion → manual replacement
Repair Principles
| Injury | Management |
|
Perineal tear (1st-2nd degree)
|
Suture in layers; vaginal mucosa → perineal muscle → skin |
|
Perineal tear (3rd-4th degree)
|
OT, experienced surgeon, proper identification of anal sphincter, layered repair, antibiotics, laxatives postop |
|
Vaginal tear
|
Suture from apex to avoid retraction and haematoma; continuous or interrupted |
|
Cervical tear
|
Start suture above apex of tear; continuous locking or interrupted; may need traction with sponge forceps |
|
Broad ligament haematoma
|
Laparotomy if expanding; evacuate, identify bleeding vessel, ligate; may need internal iliac ligation |
|
Uterine rupture
|
See Section 7 of main document |
|
Uterine inversion
|
See Section 8 of main document |
⚠️ Always inspect placenta and genital tract even if uterus well-contracted – trauma can coexist with atony
TISSUE – Retained Products Management
Retained Placenta (Not Delivered by 30 min)
| Situation | Management |
| Placenta not delivered, no haemorrhage | Ensure bladder empty; controlled cord traction; wait up to 30-60 min |
| Placenta not delivered, haemorrhage present |
Manual removal under anaesthesia
|
| Trapped placenta (cervix closing) | May need uterine relaxation (terbutaline, nitroglycerin, GA) |
| Morbidly adherent (accreta spectrum) | Senior surgeon, interventional radiology if available, prepare for hysterectomy |
Manual Removal of Placenta – Technique:
PREREQUISITES:
- Anaesthesia (regional or GA)
- Aseptic technique
- IV access and resuscitation ongoing
- Empty bladder
TECHNIQUE:
1. One hand on abdomen, steadying fundus (counter-traction)
2. Other hand (surgeon's dominant): Cone shape, follow cord
through cervix into uterine cavity
3. Find placental edge – use side of hand to develop plane
between placenta and uterine wall
4. Work around circumference with gentle side-to-side motion
5. Once fully separated, grasp placenta and withdraw
6. Immediately explore cavity for remaining fragments
7. Administer uterotonic and massage uterus
8. Confirm complete removal (examine placenta)
9. Single dose antibiotics (Ceftriaxone 1g IV or Ampicillin 2g IV)
⚠️ If plane cannot be developed (rock-hard adherence) →
STOP – suspect placenta accreta → prepare for laparotomy/hysterectomy
Retained Tissue/Clots (Placenta Delivered but Incomplete/Uterus Full of Clots)
| Situation | Management |
| Retained cotyledon/membranes | Explore uterine cavity under anaesthesia; gentle curettage with large blunt curette (avoid perforation) |
| Retained blood clots preventing contraction | Bimanual compression to express clots; may need manual exploration |
| Secondary PPH (>24h) with retained products | Ultrasound guidance; surgical evacuation; antibiotics |
THROMBIN – Coagulopathy Management
Recognition
| Sign | What It Means |
| Blood not clotting in wound/drapes | Clotting factor deficiency |
| Oozing from IV sites, gums, old punctures | Systemic coagulopathy |
| Ecchymoses appearing | Platelet/factor deficiency |
| Bedside clotting test abnormal | DIC or factor deficiency |
Bedside Clotting Test (Modified Lee-White):
1. Take 5 mL blood in plain glass tube (red-top)
2. Hold at body temperature (in your armpit or hands)
3. Tilt gently every minute
4. Normal: Firm clot in <8-10 minutes
5. Abnormal: No clot or soft/friable clot by 10 minutes →
Suspect coagulopathy; treat empirically while awaiting labs
Treatment
| Component | Product | Dose | Target |
|
Red cells
|
PRBC | Transfuse for Hb <7-8 g/dL or ongoing bleeding | Hb >7-8 g/dL |
|
Clotting factors
|
FFP | 15-20 mL/kg (typically 4-6 units) | PT/aPTT <1.5× control |
|
Fibrinogen
|
Cryoprecipitate | 10 units (or 1 pool) | Fibrinogen >2 g/L |
| Fibrinogen concentrate | 2-4 g (if available) | Fibrinogen >2 g/L | |
|
Platelets
|
Platelet concentrate | 1 adult dose (4-6 units or 1 SDP) | Platelets >50,000/μL (>75,000 if ongoing bleeding) |
Massive Transfusion Protocol (MTP)
Definition: Anticipated need for ≥10 units PRBC in 24h OR ≥4 units in 1h OR entire blood volume replaced
Activation Criteria:
- Shock Index ≥1.4
- Clinical assessment suggests massive ongoing haemorrhage
- Senior clinician decision
Protocol:
🚨 MASSIVE TRANSFUSION PROTOCOL
COMMUNICATION:
□ Call blood bank: "Activating MTP for PPH in [location]"
□ Designated person for blood collection/delivery
INITIAL PACK (while crossmatch pending):
- 4 units O-negative or group-specific PRBC
- 4 units FFP
- Arrange platelets
ONGOING (balanced resuscitation):
Ratio: PRBC : FFP : Platelets = 1 : 1 : 1
LABORATORY MONITORING (every 30-60 min):
- CBC
- PT/INR, aPTT
- Fibrinogen
- ABG with lactate
- Calcium (citrate in blood products chelates calcium)
TARGETS:
- Hb >7-8 g/dL
- Platelets >50,000/μL
- PT/aPTT <1.5× normal
- Fibrinogen >2 g/L
- Ionized Calcium >1.1 mmol/L (give Calcium gluconate if low)
- pH >7.2
- Temperature >35°C
ADJUNCTS:
- Tranexamic acid 1g IV if not already given
- Calcium gluconate 10 mL of 10% solution IV for hypocalcemia
- Warm all blood products and fluids
🚨 Hypothermia, acidosis, and hypocalcemia worsen coagulopathy. Treat aggressively.
SECTION 5: MECHANICAL AND SURGICAL INTERVENTIONS
5.1 TEMPORIZING MEASURES
External Aortic Compression
Indication: Temporizing measure during resuscitation or while preparing for surgery
TECHNIQUE:
1. Patient supine
2. Locate umbilicus
3. Make fist and place on midline, just above umbilicus
4. Press firmly downward toward vertebral column
5. Check femoral pulse with other hand – should be absent/diminished
6. Maintain until definitive measures instituted
7. Tiring – may need to rotate personnel
Bimanual Uterine Compression
Indication: Atony; temporizing while uterotonics take effect
TECHNIQUE:
1. One hand: Make fist, insert into anterior vaginal fornix
Push upward against lower uterine segment
2. Other hand: On abdomen, cup posterior wall of uterus
3. Compress uterus firmly between both hands
4. Maintain continuously until uterus contracts and remains firm
5. May need to continue for 15-30+ minutes
6. Continue uterotonics, prepare next steps
5.2 UTERINE BALLOON TAMPONADE (UBT)
Indication:
- Atony unresponsive to uterotonics
- Can be used while preparing for surgical intervention
- ”Tamponade test“ – if bleeding stops with balloon, likely atony; if continues, consider other causes or proceed to surgery
Commercial Balloons
| Product | Characteristics |
| Bakri balloon | Purpose-built, drainage channel, can measure ongoing loss |
| Ebb balloon | Dual balloon (uterine + vaginal) |
| BT-Cath | Similar to Bakri |
Condom Catheter (Resource-Limited Alternative)
Equally effective as commercial balloons
MATERIALS:
- Foley catheter (22-24 Fr) or rubber catheter
- Condom (non-lubricated preferred)
- Silk suture or string
- NS for inflation
PREPARATION:
1. Cut distal tip of Foley (if using Foley)
2. Tie condom firmly onto catheter end with silk (double tie)
3. Check for leaks by inflating with water
INSERTION:
1. Confirm uterus is empty (no retained products/clots)
2. Aseptic technique
3. Insert catheter with condom into uterine cavity
(may use sponge forceps to guide)
4. Inflate with warm NS – typically 250-500 mL
5. Inflate until resistance felt OR bleeding stops
6. Clamp catheter
7. Pack vagina lightly with gauze to prevent expulsion (optional)
8. Start or continue oxytocin infusion
9. Tape catheter to thigh
MONITORING:
- Check pad for ongoing bleeding
- Monitor vitals continuously
- Check balloon is in place
REMOVAL:
- Leave in situ for 12-24 hours
- Deflate gradually (50-100 mL at a time over several hours)
- Have uterotonics, blood ready
- Remove once fully deflated and no bleeding
Positive ”Tamponade Test“: Bleeding stops with balloon inflation → Confirms atony as cause; continue balloon therapy
Negative ”Tamponade Test“: Bleeding continues → Other cause or need for surgical intervention
5.3 UTERINE COMPRESSION SUTURES
Indication: Atony at laparotomy; failed UBT
B-Lynch Suture (Most Common)
TECHNIQUE:
Prerequisites:
- Laparotomy performed
- Uterus exteriorized
- Bladder reflected down (if not already for CS)
Test compression first:
- Assistant compresses uterus bimanually
- If bleeding stops with compression, suture will likely work
Suture material: No. 1 or No. 2 absorbable suture (Chromic catgut,
Polyglactin) on large needle
Steps:
1. Enter uterus 3 cm below right edge of incision, 3 cm from
lateral border; exit 3 cm above incision
2. Pass suture over fundus to posterior wall (approximately
4 cm from cornua)
3. Enter posterior wall at level of uterosacral ligament
insertion, exit on same level on left side
4. Pass suture back over fundus on left side
5. Enter anterior wall 3 cm above left edge of incision;
exit 3 cm below incision
6. While assistant compresses uterus, pull both ends of suture
tight and tie securely
7. Close uterine incision (if CS)
Post-procedure:
- Confirm haemostasis
- May place drain
- Consider antibiotics
Other Compression Sutures
| Suture | Description |
|
Hayman
|
Simpler; does not require uterine incision; vertical sutures from anterior to posterior |
|
Cho (Square sutures)
|
Multiple square sutures through full thickness; good for focal bleeding |
|
Pereira
|
Combination of transverse and longitudinal sutures |
5.4 VASCULAR LIGATION
Indication: Bleeding despite compression sutures or UBT; not involving uterine atony (e.g., trauma, extensions); desire to preserve fertility
Uterine Artery Ligation (O’Leary Sutures)
TECHNIQUE:
1. Identify uterine artery – runs along lateral aspect of lower
uterine segment (can often be seen pulsating)
2. Create window in broad ligament avascular area
3. Pass suture (No. 1 absorbable) through myometrium at level
of internal os, 2-3 cm medial to artery, from front to back
4. Tie on lateral side, including artery and veins
5. Repeat on other side
6. If bleeding continues, may ligate ascending branches higher
(at cornual level)
Internal Iliac (Hypogastric) Artery Ligation
Indication: Severe uncontrolled hemorrhage; experienced surgeon
TECHNIQUE OVERVIEW:
1. Open posterior peritoneum lateral to iliac vessels
2. Identify and retract ureter medially
3. Identify bifurcation of common iliac into external and
internal iliac arteries
4. Internal iliac is medial and posterior
5. Carefully dissect around internal iliac artery (avoid vein
posteriorly)
6. Pass right-angled clamp behind artery, 2-3 cm distal to
bifurcation (to preserve posterior division if possible)
7. Pass ligature and tie (do not cut artery)
8. Repeat on other side
Reduces pulse pressure by 85%, allowing clot formation
⚠️ Complications: Ureteric injury, venous injury, buttock
claudication (rare)
5.5 HYSTERECTOMY
Indication:
- Life-threatening haemorrhage unresponsive to conservative measures
- Placenta accreta spectrum with uncontrollable bleeding
- Uterine rupture not amenable to repair
- DO NOT DELAY when indicated – maternal life takes priority
When to Proceed to Hysterectomy
DECISION POINTS:
Consider hysterectomy when:
□ Massive haemorrhage despite optimal uterotonic therapy
□ Failed UBT and/or compression sutures
□ Failed vascular ligation
□ Uterine rupture with extensive damage
□ Placenta accreta/increta/percreta with uncontrollable bleeding
□ Total blood replacement approaching/exceeding
Decision must balance:
- Rate of ongoing bleeding
- Resources available (blood, surgical expertise)
- Patient stability
- Future fertility wishes (discuss if time permits, but life > fertility)
⚠️ A timely subtotal hysterectomy is better than a delayed total
hysterectomy in a dying patient
Subtotal vs Total Hysterectomy
| Type | Advantages | Disadvantages |
|
Subtotal (Supracervical)
|
Faster, less urological injury, less blood loss | Cervical stump may bleed if placenta praevia/accreta |
|
Total
|
Definitive; no cervical stump issues | Longer, more technically demanding, higher complication risk |
Choice depends on:
- Source of bleeding (low = total may be needed)
- Patient stability (unstable = subtotal and pack)
- Surgical expertise
Damage Control Surgery Concept
In extreme haemorrhage with coagulopathy, hypothermia, acidosis:
DAMAGE CONTROL APPROACH:
1. Abbreviated surgery:
- Control bleeding (hysterectomy if needed, or packing)
- Pack pelvis and close abdomen
2. ICU resuscitation:
- Warm patient
- Correct coagulopathy
- Correct acidosis
- Massive transfusion
3. Re-look surgery (24-48h):
- Remove packs
- Complete definitive repair
- Close abdomen definitively
5.6 INTERVENTIONAL RADIOLOGY (Where Available)
| Procedure | Indication |
|
Uterine artery embolization
|
Atony, accreta (pre-planned), AV malformation, pseudo-aneurysm |
|
Internal iliac artery embolization
|
Broader haemorrhage control |
|
Balloon occlusion (planned)
|
Anticipated accreta; placed before CS |
Prerequisites:
- Haemodynamically stable enough to tolerate procedure (~1h)
- Interventional radiology available 24/7
- Hybrid OR ideal
SECTION 6: BLOOD TRANSFUSION PROTOCOLS
6.1 INDICATIONS FOR TRANSFUSION
| Product | Indication | Dose |
|
PRBC
|
Hb <7 g/dL (or <8 g/dL in cardiac disease or ongoing bleeding) | 1 unit raises Hb by ~1 g/dL |
|
FFP
|
PT/INR or aPTT >1.5× normal; empiric in massive transfusion | 15-20 mL/kg |
|
Platelets
|
<50,000/μL with bleeding; <75,000/μL in ongoing haemorrhage | 1 adult dose |
|
Cryoprecipitate
|
Fibrinogen <2 g/L | 10 units |
6.2 EMERGENCY BLOOD
| Situation | Action |
|
Crossmatch available
|
Crossmatched blood (safest) |
|
No time for crossmatch
|
Type-specific uncrossmatched blood (Group compatible) |
|
Unknown blood group, life-threatening
|
O-negative PRBC (or O-positive if Rh-neg unavailable) |
🚨 Never delay transfusion for crossmatch in life-threatening haemorrhage. O-negative or group-specific blood is acceptable.
6.3 TRANSFUSION COMPLICATIONS TO WATCH FOR
| Complication | Signs | Management |
|
Transfusion reaction
|
Fever, chills, rash, dyspnoea, hypotension | Stop transfusion; supportive care; notify blood bank |
|
TACO (overload)
|
Dyspnoea, hypertension, JVP elevated | Slow/stop transfusion; diuretics |
|
TRALI
|
Acute lung injury within 6h; bilateral infiltrates, hypoxia | Supportive; oxygen; may need ventilation |
|
Hypocalcemia
|
Citrate toxicity; prolonged QT, tetany | Calcium gluconate 10 mL 10% IV |
|
Hypothermia
|
Cold products | Use blood warmer |
|
Hyperkalaemia
|
Especially old blood | Monitor potassium; treat if symptomatic |
SECTION 7: POST-RESUSCITATION CARE
7.1 IMMEDIATE POST-EVENT (First 2-6 Hours)
| Action | Details |
|
Monitoring
|
ICU/HDU level care if severe PPH; q15-30 min vitals initially |
|
Uterine tone
|
Continue to assess; continue oxytocin infusion for minimum 4 hours |
|
Urine output
|
Target ≥0.5 mL/kg/hr; Foley remains in situ |
|
Bleeding
|
Monitor pad/drapes; ongoing bleeding → reassess |
|
Labs
|
Repeat CBC, coagulation at 2-4 hours; ABG if was acidotic |
|
VTE prophylaxis
|
Graduated compression stockings; mechanical prophylaxis while bleeding risk persists |
7.2 INVESTIGATIONS TO EXCLUDE ONGOING ISSUES
| Investigation | Purpose |
| Serial CBC | Confirm Hb stable; may continue to drop with fluid shifts |
| Coagulation (PT, aPTT, fibrinogen) | Ensure normalized; guide further blood products |
| RFT | Exclude acute kidney injury |
| LFT | Baseline; especially if HELLP/preeclampsia |
| ABG/Lactate | Ensure clearance of acidosis |
| Echo | If suspected cardiac injury (AFE, massive transfusion) |
7.3 LONGER TERM CARE
| Issue | Management |
|
Anaemia
|
Oral iron supplementation; may need continued transfusion if symptomatic/Hb <7 |
|
Sheehan syndrome
|
Suspect if failure to lactate; test pituitary function (TSH, cortisol, etc.) |
|
Thromboprophylaxis
|
Low molecular weight heparin once haemostasis secured (usually 24-48h post); balance bleeding vs clot risk |
|
Psychological
|
Debrief patient; watch for PTSD; offer counseling |
|
Contraception
|
Discuss timing of future pregnancy; may need interval for recovery |
7.4 IRON REPLACEMENT THERAPY
| Route | Indication | Options |
|
Oral
|
Mild-moderate anaemia, tolerating oral | Ferrous sulfate 200 mg TDS (60 mg elemental iron TDS); take with vitamin C; avoid with tea/antacids |
|
IV
|
Severe anaemia (Hb <8), intolerance to oral, rapid correction needed | Ferric carboxymaltose 1000 mg single dose (or 500 mg × 2); Iron sucrose 200 mg × 5 doses |
SECTION 8: SPECIAL SITUATIONS
8.1 SECONDARY PPH (>24 Hours – 12 Weeks)
Causes
| Cause | Frequency |
| Subinvolution of placental site ± infection | Most common |
| Retained products of conception | Common |
| Endometritis | Common |
| Pseudoaneurysm of uterine artery | Rare |
| Gestational trophoblastic disease | Rare |
Management
ASSESSMENT:
□ Vitals, shock assessment
□ Bleeding – amount, clots
□ Signs of infection – fever, offensive lochia, uterine tenderness
□ Speculum – source of bleeding, cervical os open?
□ Bimanual – uterine size, tenderness
INVESTIGATIONS:
□ CBC, Group & Save
□ Ultrasound – retained products? Endometrial thickness >10mm?
□ βhCG if GTD suspected
TREATMENT:
1. Resuscitation if needed (as per primary PPH)
2. Uterotonics:
- Oxytocin 10 IU IM + infusion
- Misoprostol 400-600 mcg SL/PO
3. Antibiotics (presumptive infection):
- Ampicillin + Gentamicin + Metronidazole
- OR Amoxicillin-clavulanate + Metronidazole
4. Surgical evacuation if retained products:
- Ultrasound-guided if possible
- Gentle suction curettage
- Risk of perforation (soft postpartum uterus)
5. Consider embolization if AV malformation/pseudoaneurysm
6. Rarely → hysterectomy if uncontrolled
8.2 JEHOVAH’S WITNESS (REFUSAL OF BLOOD)
Principles
- Respect autonomy if competent adult with informed refusal
- Document advance directive clearly
- Optimize alternatives
- Discuss with hospital ethics/legal if needed
Alternatives to Blood Transfusion
| Intervention | Details |
|
Cell salvage
|
May be acceptable to some JW (own blood recycled) |
|
Tranexamic acid
|
Give early |
|
IV Iron
|
Pre-operatively if time |
|
Erythropoietin
|
Pre-operatively if time (EPO 40,000 units SC weekly) |
|
Minimize blood loss
|
Meticulous haemostasis, UBT, compression sutures |
|
Tolerate lower Hb
|
May tolerate Hb as low as 5-6 g/dL if normovolemic and not bleeding |
|
Minimize phlebotomy
|
Paediatric tubes; minimize testing |
8.3 PPH AFTER CAESAREAN SECTION
| Additional Considerations | Details |
| Higher expected blood loss | 1000 mL threshold for ”severe“ |
| Visible causes | Extensions of incision, broad ligament haematoma, coagulopathy |
| Lower segment atony | May need figure-of-8 sutures at angles |
| Placenta accreta spectrum | Higher risk if previous CS + anterior placenta |
| Rapid access to abdominal cavity | Already open or can re-open quickly |
8.4 JEERING WITH PLACENTA ACCRETA SPECTRUM
Risk Factors
| Factor | Relative Risk |
| Previous CS + Placenta praevia | Highest risk |
| 1 prior CS + praevia | ~3% accreta |
| 2 prior CS + praevia | ~11% accreta |
| ≥3 prior CS + praevia | ~40% accreta |
| Previous myomectomy | Increased risk |
| Previous curettage | Increased risk |
Pre-operative Planning (Suspected Accreta)
MULTIDISCIPLINARY PLANNING:
Team:
□ Senior obstetrician (experienced in accreta)
□ Senior anaesthetist
□ Blood bank (crossmatch ≥6 units PRBC, FFP, platelets on standby)
□ Interventional radiology (if available)
□ Urology (if bladder involvement suspected)
□ ICU
Pre-operative:
□ Confirm diagnosis (MRI if unclear on USS)
□ Counseling – high likelihood of hysterectomy
□ Consent for hysterectomy
□ Cell salvage available
□ Adequate IV access (large bore × 2, ± central line)
□ Arterial line
□ Warm products and fluids
Operative strategy:
□ Midline vertical incision (adequate access)
□ Classical uterine incision (avoid placenta)
□ Deliver baby
□ DO NOT attempt to remove placenta if accreta confirmed
□ Hysterectomy with placenta in situ
□ Consider ureteric stents pre-op if percreta
□ Consider iliac balloon catheters (IR)
SECTION 9: DOCUMENTATION
9.1 ESSENTIAL DOCUMENTATION
PPH DOCUMENTATION CHECKLIST:
□ Time PPH recognised
□ Estimated blood loss (method used)
□ Vitals at recognition and serially
□ Shock Index
□ Team members present
□ Call for help time
□ Uterotonic drugs given (drug, dose, route, time)
□ Tranexamic acid (dose, time)
□ IV fluids (type, volume, time)
□ Blood products (type, units, time)
□ Procedures performed:
- Uterine massage
- Bimanual compression
- UBT (type, volume, time in/out)
- Examination under anaesthesia
- Surgical procedures (detail technique, suture material)
□ Cause identified (Tone/Trauma/Tissue/Thrombin)
□ Placenta and membrane – complete/incomplete
□ Repairs performed (tears – degree, location)
□ Total blood loss
□ Vital signs at end
□ Transfer to ICU/HDU (time, receiving team)
□ Communication with family
9.2 DEBRIEF
TEAM DEBRIEF (Within 24 hours):
1. What went well?
2. What could be improved?
3. Were protocols followed?
4. Any equipment/supply issues?
5. Any communication issues?
6. Learning points for the team
7. Support for team members (especially if adverse outcome)
Document key learning points and action items
9.3 PATIENT DEBRIEF
| Component | Details |
|
Timing
|
Before discharge and at postnatal follow-up |
|
What happened
|
Explain events in understandable terms |
|
Why it happened
|
Cause if known |
|
What was done
|
Interventions, transfusions, surgery |
|
Implications
|
Effect on future fertility/pregnancies |
|
Emotional support
|
Acknowledge trauma; offer counseling if needed |
|
Written summary
|
Provide discharge summary with key details |
|
Follow-up plan
|
When to return, red flags |
SECTION 10: SIMULATION AND DRILLS
10.1 IMPORTANCE OF DRILLS
- PPH is unpredictable and progresses rapidly
- Team coordination is critical
- Regular drills improve response time and outcomes
- Identifies system gaps (equipment, protocols, communication)
10.2 RECOMMENDED DRILL FREQUENCY
| Type | Frequency |
|
PPH simulation
|
Monthly at minimum |
|
MTP activation drill
|
Quarterly |
|
Full team drill with debrief
|
Quarterly |
QUICK REFERENCE CARDS
📋 PPH QUICK CARD (PRIMARY CARE)
🚨 PPH RECOGNISED – START CLOCK
□ CALL FOR HELP + ACTIVATE REFERRAL
□ A – Airway, Breathing, Oxygen (8-10 L/min)
□ C – 2 large-bore IV (16-18G)
Crystalloid 1-2 L rapid bolus
Bloods: Group, X-match, CBC, Coag
□ M – MASSAGE uterus (bimanual)
□ O – OXYTOCIN 10 IU IM + infusion 20-40 IU in 500 mL NS
MISOPROSTOL 800 mcg SL (if oxytocin inadequate)
□ T – TRANEXAMIC ACID 1 g IV over 10 min (within 3h)
□ I – Identify cause (Tone / Trauma / Tissue / Thrombin)
Empty bladder (catheterize)
Examine placenta, genital tract
□ V – Vital signs q5-15 min; Shock Index
□ E – Escalate / Transfer if:
- Bleeding continues despite above
- Shock Index ≥1.0
- Needs transfusion or surgery
□ NASG if available during transfer
□ Continue massage, uterotonics, IV during transport
RECEIVING FACILITY: _______________
CONTACT: _______________
ETA: _______________
📋 PPH QUICK CARD (SECONDARY/TERTIARY)
🚨 SEVERE PPH / REFRACTORY TO FIRST-LINE
TIME: _____ TEAM LEADER: _____
□ CONFIRM adequate resuscitation:
- 2 large IV, rapid crystalloid 1-2L
- Tranexamic acid 1g given
- Oxytocin loading + infusion running
- Misoprostol given
- Uterine massage ongoing
□ ADD second-line uterotonics:
- Methylergometrine 0.2 mg IM (if no HTN)
- Carboprost 250 mcg IM q15min (if no asthma)
□ IDENTIFY CAUSE:
- Atony → continue massage, bimanual compression
- Trauma → EUA, repair
- Tissue → MVA/curettage under anaesthesia
- Thrombin → blood products (FFP, cryo, platelets)
□ ACTIVATE MTP if Shock Index ≥1.4 or massive ongoing loss
- PRBC : FFP : Platelets = 1:1:1
- Target Hb >8, Plt >50k, Fib >2, Ca++, correct acidosis
□ UTERINE BALLOON TAMPONADE:
- Bakri or condom catheter
- Inflate 250-500 mL NS
- If bleeding stops → leave 12-24h
- If bleeding continues → OT
□ LAPAROTOMY if UBT fails or cause surgical:
- Compression sutures (B-Lynch, Hayman)
- Uterine artery ligation
- Internal iliac ligation
- HYSTERECTOMY (don't delay if life-saving)
□ POST-RESUSCITATION:
- ICU/HDU transfer
- Continue uterotonics 4h
- Serial labs
- Debrief patient and team
TOTAL BLOOD LOSS: _____ mL
PRODUCTS GIVEN: _____
PROCEDURES: _____
📚 REFERENCES FOR PPH PROTOCOL
INTERNATIONAL GUIDELINES (Primary Evidence Base)
Reference Year Key Content Used
1 WHO recommendations for the prevention and treatment of postpartum haemorrhage 2012, Updated 2023 Uterotonics, TXA, UBT, AMTSL, overall management algorithm
2 WHO recommendations on tranexamic acid for the treatment of postpartum haemorrhage 2017 TXA dosing, timing (within 3 hours)
3 FIGO recommendations on the prevention and treatment of postpartum hemorrhage 2022 Stepwise approach, second-line uterotonics, surgical interventions
4 RCOG Green-top Guideline No. 52: Prevention and Management of Postpartum Haemorrhage 2016 (under review) Risk stratification, mechanical interventions, surgical techniques
5 ACOG Practice Bulletin No. 183: Postpartum Hemorrhage 2017, Reaffirmed 2019 Quantitative blood loss, massive transfusion
6 International Society of Blood Transfusion (ISBT) – Massive Transfusion Guidelines 2020 MTP ratios, targets
KEY TRIALS
2 WHO recommendations on tranexamic acid for the treatment of postpartum haemorrhage 2017 TXA dosing, timing (within 3 hours)
3 FIGO recommendations on the prevention and treatment of postpartum hemorrhage 2022 Stepwise approach, second-line uterotonics, surgical interventions
4 RCOG Green-top Guideline No. 52: Prevention and Management of Postpartum Haemorrhage 2016 (under review) Risk stratification, mechanical interventions, surgical techniques
5 ACOG Practice Bulletin No. 183: Postpartum Hemorrhage 2017, Reaffirmed 2019 Quantitative blood loss, massive transfusion
6 International Society of Blood Transfusion (ISBT) – Massive Transfusion Guidelines 2020 MTP ratios, targets
KEY TRIALS
Trial/Study Journal/Year Key Finding Used
7 WOMAN Trial (World Maternal Antifibrinolytic Trial) Lancet 2017 TXA reduces death from bleeding by ~20-30% if given within 3 hours
8 WOMAN-2 Trial Lancet Global Health 2023 TXA in anaemic women (ongoing/results)
9 WHO Multicountry Survey on Maternal and Newborn Health BJOG 2014 PPH epidemiology, risk factors
10 Cochrane Review: Uterotonic agents for preventing PPH Cochrane 2018, Updated 2020 Comparative effectiveness of uterotonics
11 Cochrane Review: Uterine balloon tamponade for PPH Cochrane 2020 Evidence for UBT effectiveness
12 ESA-ESICM Guidelines on Massive Hemorrhage Eur J Anaesthesiol 2023 Coagulopathy management, transfusion targets
INDIAN GUIDELINES & GOVERNMENT DOCUMENTS
8 WOMAN-2 Trial Lancet Global Health 2023 TXA in anaemic women (ongoing/results)
9 WHO Multicountry Survey on Maternal and Newborn Health BJOG 2014 PPH epidemiology, risk factors
10 Cochrane Review: Uterotonic agents for preventing PPH Cochrane 2018, Updated 2020 Comparative effectiveness of uterotonics
11 Cochrane Review: Uterine balloon tamponade for PPH Cochrane 2020 Evidence for UBT effectiveness
12 ESA-ESICM Guidelines on Massive Hemorrhage Eur J Anaesthesiol 2023 Coagulopathy management, transfusion targets
INDIAN GUIDELINES & GOVERNMENT DOCUMENTS
Reference Issuing Body Year Key Content
13 FOGSI GCPR on Prevention and Management of PPH Federation of Obstetric & Gynaecological Societies of India 2016, Updated 2021 India-specific recommendations, drug availability
14 LaQshya – Labour Room Quality Improvement Initiative Guidelines Ministry of Health & Family Welfare, Government of India 2017 Labour room protocols, emergency management
15 Skilled Birth Attendant (SBA) Training Module Government of India 2010, Revised AMTSL, initial PPH management at primary level
16 Guidelines for BEmONC (Basic Emergency Obstetric and Newborn Care) Government of India 2010 Primary care level management
17 Guidelines for CEmONC (Comprehensive Emergency Obstetric and Newborn Care) Government of India 2010 Referral level management, surgical interventions
18 Maternal and Newborn Health Toolkit Ministry of Health & Family Welfare 2013 Operational guidelines for facilities
19 FOGSI Position Paper on Use of Tranexamic Acid in PPH FOGSI 2018 TXA adoption in India
20 National Guidelines for Blood Transfusion Services NACO/NBTC 2020 Blood transfusion protocols for India
21 Maternal Death Surveillance and Response (MDSR) Guidelines Government of India 2017 Reporting, review of maternal deaths
22 ICMR-FOGSI Guidelines on Iron Deficiency Anaemia in Pregnancy ICMR/FOGSI 2021 Anaemia management context
TEXTBOOKS & ADDITIONAL RESOURCES
14 LaQshya – Labour Room Quality Improvement Initiative Guidelines Ministry of Health & Family Welfare, Government of India 2017 Labour room protocols, emergency management
15 Skilled Birth Attendant (SBA) Training Module Government of India 2010, Revised AMTSL, initial PPH management at primary level
16 Guidelines for BEmONC (Basic Emergency Obstetric and Newborn Care) Government of India 2010 Primary care level management
17 Guidelines for CEmONC (Comprehensive Emergency Obstetric and Newborn Care) Government of India 2010 Referral level management, surgical interventions
18 Maternal and Newborn Health Toolkit Ministry of Health & Family Welfare 2013 Operational guidelines for facilities
19 FOGSI Position Paper on Use of Tranexamic Acid in PPH FOGSI 2018 TXA adoption in India
20 National Guidelines for Blood Transfusion Services NACO/NBTC 2020 Blood transfusion protocols for India
21 Maternal Death Surveillance and Response (MDSR) Guidelines Government of India 2017 Reporting, review of maternal deaths
22 ICMR-FOGSI Guidelines on Iron Deficiency Anaemia in Pregnancy ICMR/FOGSI 2021 Anaemia management context
TEXTBOOKS & ADDITIONAL RESOURCES
Reference Details
23 Williams Obstetrics 26th Edition (2022) Chapter on Obstetric Hemorrhage
24 Arias’ Practical Guide to High-Risk Pregnancy and Delivery 4th Edition PPH management
25 DC Dutta’s Textbook of Obstetrics 9th Edition (2018) Commonly used Indian textbook
26 Management of Labour – FOGSI Focus Series Practical guidance
27 B-Lynch Suture Technique – Original description B-Lynch et al., BJOG 1997
ONLINE RESOURCES
24 Arias’ Practical Guide to High-Risk Pregnancy and Delivery 4th Edition PPH management
25 DC Dutta’s Textbook of Obstetrics 9th Edition (2018) Commonly used Indian textbook
26 Management of Labour – FOGSI Focus Series Practical guidance
27 B-Lynch Suture Technique – Original description B-Lynch et al., BJOG 1997
ONLINE RESOURCES
🛡️
Medical Advisory
Clinical guidelines are subject to change. Physicians should exercise their regular clinical judgment. This protocol does not replace individual institutional policies. Verified for Q1 2026.
Content Feedback
Is this information helpful?
Help us improve our clinical database for the medical community.